Testing laboratory · Reviewed 2026-10-06
Liquilabs s.r.o. · Zlatníky-Hodkovice, Czech Republic
Legitimacy review
Liquilabs is a real registered analytical-testing business with public issuer records and detailed peptide reports. PeptidePrices verified 42 current Adria files against the laboratory's own complete PDFs. Its current ISO/IEC 17025 accreditation and independent proficiency performance remain unconfirmed.
The Czech Ministry of Finance's ARES and commercial-register records identify active Liquilabs s.r.o., company ID 22067787, formed September 19, 2024. Ján Galbavý is its sole registered shareholder and director and signs the reviewed reports as CEO. Its registered office is Grafická 3365/1, Prague-Smíchov; the laboratory website and current certificates give Inovační 122, Zlatníky-Hodkovice, as the contact address.
A primary company record, a named owner and report signer, complete official issuer PDFs, and detailed analytical appendices. The October 6 Adria audit independently matched 42 files covering 360 pages; this is a defined customer collection, not a total count of the laboratory's work.
Searches of the Czech Accreditation Institute's official database by Liquilabs name and company ID returned zero records on October 6, 2026. No current accreditation certificate or analytical scope naming Liquilabs was found. References to USP or European Pharmacopoeia methods on a report identify the stated method, rather than accrediting the laboratory.
Reviewed peptide reports show UV/PDA content and chromatographic purity, retention-time and FTIR identity scores, and LC-MS molecular-mass evidence on selected samples. Other official files report chromogenic endotoxin, USP <61> aerobic and yeast/mold counts, and elemental impurities. The service menu advertises HPLC-UV/HPLC-MS and ICP-MS or AAS for metals. Individual panel availability, price, sample requirements and turnaround are quoted directly; no current published price or guaranteed turnaround was confirmed.
There is no substantial verified lab-customer rating or published independent proficiency study in the reviewed sources. Vendor accounts describe successful testing and a laboratory visit. Older Liquilabs and Cellgenic documents share instrument identifiers. Particle attributes this to secondhand and leased equipment; the acquisition records and raw analytical data remain unconfirmed.
No confirmed accreditation scope, independent proficiency dataset, public custody policy or complete method-validation package was located. Two specific report questions—LYO-0499 wavelength wording and LYO-0399 copper-complex identity—remain open. Public issuer files establish issuance. Customer-selected samples, commercial laboratory visits and self-published methods are different evidence from independent performance testing.
Liquilabs s.r.o. has a confirmed Czech company record dating to September 19, 2024. The registered owner and director, Ján Galbavý, is also the signer on the inspected reports. The laboratory's public contact location and its registered office are distinct and both are disclosed. Earlier certificates use other Prague laboratory addresses; their printed addresses remain historical report information.
Its public report links return complete PDFs without an account. All 42 current Adria Science files matched their specific official copies byte for byte, including all 360 pages. That is meaningful evidence of an operating report service. It is not a census of every Liquilabs test or a substitute for a laboratory inspection.
The official Czech accreditation database returned no Liquilabs entry when searched by its name or company ID on October 6, 2026. A current ISO/IEC 17025 certificate and scope therefore remain unconfirmed. The laboratory describes validated methods and offers method-development services, but no complete peptide validation dossier or independent proficiency results were found publicly.
Some directories describe Liquilabs as a long-established family laboratory. The primary record supports a company formed in September 2024; it does not establish that longer history. The registered capital is a company-registration figure, rather than evidence of the cost, ownership or financing of its instruments.
LYO-0499 names a Shimadzu LC-40B XR pump, SIL-40C XR autosampler, SPD-M40 PDA detector and LCMS-2050 single-quadrupole mass detector. Its appendices give sample preparation, a five-point external calibration, separation conditions, chromatograms, a mass-spectrum comparison and an endotoxin worksheet. These details make the report more informative than a summary purity badge. Instrument names and serial numbers printed in a report are documentary evidence; equipment ownership and calibration status were not independently inspected.
Content, purity and identity answer different questions. Content is the calibrated amount recovered from the submitted container; purity is the proportion of detected chromatographic peak area under the stated conditions; identity is supported by the particular retention-time, FTIR or mass evidence shown. Bioburden plate counts measure microbial load and should not be described as sterility culture. A report must actually include endotoxin or metals before those results can be attributed to its sample.
LYO-0499 specifies a 225 nm purity wavelength in its method table and chromatogram, while adjacent method prose says 214 nm. The inconsistency is in the document itself and should be clarified by the issuer. It does not alter the fact that the official file matches the supplied report.
The GHK-Cu report LYO-0399 prints a molecular mass of 341. Adria's public response attributes that signal to copper dissociation during analysis with acidic TFA and says the UV assay was calibrated against GHK-Cu reference material. That is a specific methodological explanation from the vendor, attributed to Liquilabs. Establishing the intact copper complex still calls for the reference documentation and a clear explanation of the FTIR comparison and mass-peak assignments; a high chromatographic purity alone does not settle that question.
An April 2, 2026 Reddit post alleged copied instrument serial numbers and fabricated testing in connection with Particle Peptides. The overlap is real in two supplier-hosted documents checked here: Liquilabs' LYO-0140 Selank report on Eurochem and Cellgenic's December 2025 Glow Stack certificate both print controller C21014112659 and autosampler C21054109114. Cellgenic's document is branded and signed by Cellgenic, rather than naming Liquilabs as its testing laboratory. Its peak tables are described as representative reference-standard data. These documents establish shared instrument identifiers; equipment location, ownership and the underlying sample acquisition files still need reconciliation.
Particle's April 14, 2026 response says some components were bought secondhand, some were leased, and Liquilabs had acquired additional HPLC systems from a US supplier. That is an attributed vendor explanation; transfer, lease and calibration records were not supplied in the public sources reviewed. Current Adria reports name a different Shimadzu 40-series configuration. Shared national origin does not establish common ownership, and registered capital is not an equipment budget. The checked documents support a specific equipment-provenance question, rather than a finding that all Liquilabs measurements were fabricated.
The supplier 24Peptides describes visiting Liquilabs and seeing its equipment and process. That is a disclosed customer account, not an independent inspection. No substantial verified lab-customer aggregate or controlled interlaboratory performance study was found. The useful current conclusion is a traceable analytical-report business with detailed documentation and a still limited independent performance record.
Use the exact Verify Results Online link or QR destination and confirm the host is base.liquilabs.cz. Preserve the ar_uid token. Compare the whole official PDF with the supplied file, including its client, compound, batch, laboratory sample number, results and appendices; a screenshot of the first page omits important evidence.
The endpoint returned an explicit no-object message for a nonexistent token with HTTP 200 during this check. A response status is therefore insufficient to verify a report. A valid PDF confirms issuance; the product's exact batch and the custody of its submitted sample are separate checks.
COA verification
Open the certificate's Verify Results Online link or QR code on base.liquilabs.cz. The ar_uid token identifies the official complete PDF. Compare the client, sample name, batch, LYO or LIQ sample number, publication date, results, and every appendix with the supplied report.
Result handling
The token returns an official PDF whose client, sample, batch, results and complete pages agree with the supplied file. All 42 current Adria files matched byte for byte on October 6, 2026.
A functioning report endpoint explicitly says it found no object for the submitted token. The checked nonexistent token returned that message with HTTP 200, so a successful HTTP status alone is insufficient.
The official PDF resolves but a material client, sample, batch, result or appendix differs. Preserve the actual disagreement and the complete files.
A timeout, login barrier or failed response leaves issuance unresolved. Recheck the certificate's own destination before interpreting the result.
Liquilabs is outside the fixed automated checker roster. Its archive reports can still be independently matched to specific public issuer PDFs.
The certificate lacks a working token or the issuer record cannot be compared. Keep the retained document available without an issuer-verified label.
Certificate structure
Keep the complete PDF, including instrument and method tables, sample preparation, calibration, chromatograms, mass spectra, any contamination worksheets, and the signed final page. The reviewed Adria collection contains 42 complete files and 360 pages.
Count the tests actually reported. Adria's current set contains 28 compound reports with identity, purity, content and endotoxin; 11 with identity, purity and content; two blends with component assays and retention-time identity; and one diluent report with preservative, pH and endotoxin. Other Liquilabs reports include bioburden and metals. That broader capability does not add those panels to Adria's reports.
Evidence boundaries
Review receipts
Public search record
Results include the laboratory's own service pages and public PDFs, Czech company records, vendor report libraries, and a small number of customer disputes. Several directories say no verifier is available, although working report-specific Liquilabs links exist. Published claims of a long family operating history or a fully in-house method menu were not substantiated by the primary records reviewed here.
Sources
Reusable integration rule: Preserve the certificate's exact ar_uid, match the complete official PDF, and publish only the tests shown in that report. Keep analytical questions, accreditation, vendor attribution, and current-product batch matching separate.
Frequently asked questions
Yes. Liquilabs is a real registered analytical-testing business with public issuer records and detailed peptide reports. PeptidePrices verified 42 current Adria files against the laboratory's own complete PDFs. Its current ISO/IEC 17025 accreditation and independent proficiency performance remain unconfirmed.
Reviewed peptide reports show UV/PDA content and chromatographic purity, retention-time and FTIR identity scores, and LC-MS molecular-mass evidence on selected samples. Other official files report chromogenic endotoxin, USP <61> aerobic and yeast/mold counts, and elemental impurities. The service menu advertises HPLC-UV/HPLC-MS and ICP-MS or AAS for metals. Individual panel availability, price, sample requirements and turnaround are quoted directly; no current published price or guaranteed turnaround was confirmed.
No ISO/IEC 17025 accreditation confirmed. Searches of the Czech Accreditation Institute's official database by Liquilabs name and company ID returned zero records on October 6, 2026. No current accreditation certificate or analytical scope naming Liquilabs was found. References to USP or European Pharmacopoeia methods on a report identify the stated method, rather than accrediting the laboratory.
Open the certificate's Verify Results Online link or QR code on base.liquilabs.cz. The ar_uid token identifies the official complete PDF. Compare the client, sample name, batch, LYO or LIQ sample number, publication date, results, and every appendix with the supplied report.
The reviewed sources did not establish that vendors can purchase a passing result from Liquilabs. That is not an audited independence guarantee: sample selection, who pays, publication rights, blind-testing controls, and correction history still matter.
The supplied reports do not document a retail purchase, blind sample collection, sealed custody transfers, or a link to every shipped vial. A matching batch report applies to the identified submitted sample.
A timeout, login barrier or failed response leaves issuance unresolved. Recheck the certificate's own destination before interpreting the result.
Check the document
